Sun Pharma to make upfront payment worth Rs 2.40 bn to CSIR-IICT Hyderabad for new drug compounds

This collaboration with CSIR-IICT for developing new drugs is part of our broader strategy for enhancing our global specialty pipeline.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/30bJFMN
via IFTTT